J 2017

Human dietary intake and hazard characterization for residues of neonicotinoides and organophosphorus pesticides in Egyptian honey

AL NAGGAR, Yahya, Garry Paul CODLING a John P. GIESY

Základní údaje

Originální název

Human dietary intake and hazard characterization for residues of neonicotinoides and organophosphorus pesticides in Egyptian honey

Autoři

AL NAGGAR, Yahya (818 Egypt), Garry Paul CODLING (826 Velká Británie a Severní Irsko, garant, domácí) a John P. GIESY (124 Kanada)

Vydání

Toxicological and Environmental Chemistry, ABINGDON, TAYLOR AND FRANCIS LTD, 2017, 0277-2248

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10511 Environmental sciences

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 0.972

Kód RIV

RIV/00216224:14310/17:00100206

Organizační jednotka

Přírodovědecká fakulta

UT WoS

000417587800009

Klíčová slova anglicky

Pesticides; honey; hazard index; mixture risk assessment

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 4. 4. 2018 14:50, Ing. Nicole Zrilić

Anotace

V originále

In two recently published reports, hazards posed by dietary exposure to organophosphate and neonicotinoid plant protection products on the European honey bee (Apis mellifera L.) in Egypt were investigated. Using concentrations reported in those studies, an assessment of hazards posed by these two classes of insecticides to humans due to consumption of Egyptian honey from the Nile Delta during both spring and summer was performed. Twenty-eight compounds including metabolites were assessed for exposure of adult Egyptians based on the best- and worst-case scenarios. Even for the worst-case scenario, exposure to these two classes of pesticides in honey was 15-fold less than hazard index value of 1.0 for adverse effects on humans. Based upon this analysis, people exposed to these insecticides through consumption of honey products would be unlikely to exhibit adverse health outcomes.